Bitte beachten Sie: Diese Stellenanzeige ist nicht mehr aktiv.
Entdecken Sie hier weitere Stellenanzeigen. Um regelmäßig per E-Mail über passende Stellen informiert zu werden, können Sie sich jederzeit kostenlos registrieren.
Associate Professorship (W2) in Precision Medicine of Chronic Lung Disease
Veröffentlicht am(vor 90 Tagen)
Bewerbungsende(vor 37 Tagen)
Charité - Universitätsmedizin Berlin / Berlin Institute of HealthBerlin
The Charité is one of the largest university hospitals in Europe and represents
a single medical faculty, which serves both Humboldt Universtität zu
Berlin and Freie Universität Berlin. Our clinical care, research and teaching is
delivered by physicians and researchers of the highest international standard.
Charité proudly lays claim to more than half of all German Nobel Prize
winners in Physiology or Medicine. Charité is internationally renowned for its
excellence in teaching and training. Charité extends over four campuses, and
has about 100 different Departments and Institutes, clustered in 17 Charité-
Centers. Today, the Charité is one of the largest employers in Berlin, employing
13,200 staff and with a total annual turnover of €1.6 billion. Charité is
certified by the audit "family-friendly university" and a member of the "Dual
Career Network Berlin" (www.dualcareer-berlin.de).
Berlin Institute of Health (BIH) is a biomedical research institution focusing
on translational research and precision medicine. BIH is dedicated to
improving the prediction in progressive diseases and developing advanced
therapies for unmet medical needs in order to improve patients’ health and
quality of life. The Institute is committed to providing excellent research
solutions and innovation enabling value-based, personalized healthcare.
The two founding institutions, Charité - Universitätsmedizin Berlin and Max
Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC),
are independent, member entities within BIH.
Charité - Universitätsmedizin Berlin and Berlin Institute of Health (BIH) jointly
invite applications for the following position commencing as soon as possible:
Associate Professorship in Precision Medicine of Chronic Lung Disease
(Salary group: W2 BBesG)
Reference number: Prof. 517/2018
The employment will be for five years with the possibility of further extension
following successful evaluation.
This professorship is part of the BIH Program 'Personalized Medicine for
Progressive Diseases’. Important conceptual contributions to the program
are expected. Furthermore, the professorship is a central component of the
translational research program for cystic fibrosis and other chronic lung diseases
being established in the Department of Pediatric Pulmonology and
Immunology and Cystic Fibrosis Center of the Charité. The ideal candidate
is expected to have experience with patient-derived cell culture models and
multi-assay platforms for functional analysis of epithelial ion transport, as
well as their use for investigations on the pathogenesis and development
of personalized therapies for cystic fibrosis or others severe lung diseases.
Cystic fibrosis, due to the recent breakthrough in development of the first
causal therapies, offers a monogenic model disease to prospectively develop
effective personalized therapies for other chronic lung diseases, such as
primary ciliary dyskinesia (PCD), asthma and bronchiectasis. The successful
candidate is expected to establish this innovative area and develop it sustainably
in Berlin. Additionally, the professorship is expected to play an important
role in establishing research collaborations with the German Center
for Lung Research (DZL), as well as other collaborative research projects in
the area of personalized medicine and translational research of chronic lung
Charité and BIH seek to fill this position with an outstanding, internationally
recognized scientist with an excellent track record and experience in the
fields of lung research with a focus on chronic lung diseases such as cystic
fibrosis. The research of the candidate should have translational potential. A
publication record demonstrating high-impact research and a funding record
are expected. Experience with initiation of third-party funded, interdisciplinary
national and international research projects are desirable. The successful
candidate will be engaged in teaching activities at Charité, BIH, and
MDC, supervise Master and Doctoral candidates, and participate in academic
Qualifications: as per § 100 Berlin Higher Education Act (BerlHG) junior
professorship or postdoctoral thesis (Habilitation), or equivalent scientific
achievement and teaching qualification. Completed university degree as well
as doctorate (Ph.D and/or M.D.) in medicine or natural sciences with significant
Charité and BIH are committed to increasing the proportion of women among
the scientific staff, therefore we strongly encourage women to apply. Women
will be given preference over equally qualified men (within the framework of
the legal possibilities). Candidates with immigrant background who fulfill the
necessary requirements are explicitly encouraged to apply. Equally qualified
applicants with disabilities will be given preference.
Charité is certified by the audit "family-friendly university" and a member of
the "Dual Career Network Berlin" (www.dualcareer-berlin.de).
Written applications according to the format specified on
https://career.charite.de/am/calls/application_notes.pdf should be submitted by 17 August
2018 at https://career.charite.de.
Informal inquiries about the position should be
directed to the Director of the Department of the
Department of Pediatric Pulmonology and Immunology
and Cystic Fibrosis Center, Prof. Dr. Marcus A. Mall
Erschienen auf academics.de am 25. Juni 2018
Bitte beziehen Sie sich in Ihrer Bewerbung auf den Stellenmarkt
Um unsere Webseite optimal gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen sowie Hinweise dazu, wie Sie die Speicherung der Cookies verhindern können, finden Sie in unserer Datenschutzerklärung.